ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2019

Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study.

Nagesh Kamat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.